FIBROCELL SCIENCE INC Chart calendar Fibrocell Science Inc
024668f825ab48d.zgMWdNVwQezbrdok3oyZ5Be9lCRJCIqvom0AcwCH03E.m0RnHopJEq2j7IBcn9z7qFTXpkZwQdjD6l1ILDDY4Tr_UHkkvgUqgoT6jw~e0fd4c2d8b2706cd745d27f73db43df4
Upcoming events on Fibrocell Science Inc
No events available
Past events on Fibrocell Science Inc
| 09/12/2019 | Extraordinary Shareholders Meeting - M&A Vote |
| 21/10/2019 | BIO Investor Forum |
| 15/08/2019 13:30 | Interim 2019 Earnings Call |
| 14/08/2019 21:45 | Interim 2019 Earnings Release |
| 11/06/2019 | Annual General Meeting |
| 15/05/2019 13:30 | Q1 2019 Earnings Call |
| 14/05/2019 | Q1 2019 Earnings Release Pre-market |
| 27/03/2019 12:30 | FY 2018 Earnings Call |
| 26/03/2019 | FY 2018 Earnings Release Pre-market |
| 11/02/2019 14:45 | BIO CEO & Investor Conference |
| 13/11/2018 13:30 | Q3 2018 Earnings Call |
| 12/11/2018 | Q3 2018 Earnings Release Pre-market |
| 09/10/2018 12:30 | Chardan Genetic Medicines Conference |
| 03/10/2018 23:00 | Alliance for Regenerative Medicine Cell & Gene Meeting |
| 05/09/2018 19:35 | Rodman & Renshaw Global Investment Conference |
| 09/08/2018 13:30 | Interim 2018 Earnings Call |
| 08/08/2018 | Interim 2018 Earnings Release Pre-market |
| 23/05/2018 13:30 | Annual General Meeting |
| 21/05/2018 13:30 | FCX 007 Phase 1/2 Trial Results Call |
| 18/05/2018 | International Investigative Dermatology |
More events
Past sector events for Fibrocell Science Inc
| 10/05/2024 12:00 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 09/05/2024 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 21:10 | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
